Zobrazeno 1 - 10 of 684 pro vyhledávání: '"X. Le-Loët"'
1
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study
Autor: S. Grigioni, Anne-Priscille Trouvin, H. Boulard, Emmanuel Curis, Olivier Boyer, A. Roucheux, Olivier Vittecoq, Vincent Goëb, Serge Jacquot, X. Le Loët, I. Dedreux
Publikováno v: Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2015, 180 (1), pp.11-18. ⟨10.1111/cei.12481⟩
Summary Our objective was to evaluate the contribution of monitoring B cell subset depletion after rituximab in patients with rheumatoid arthritis (RA) in order to guide reintroduction to forestall relapse. This prospective, monocentre study included
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3acf26746cdbdd66c5a6c83d09fec6f8
https://doi.org/10.1111/cei.12481
Zobrazit plný text záznamu
2
Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry
Autor: Elisabeth Solau-Gervais, Bernard Combe, Elodie Perrodeau, S. Rist, O. Meyer, J.-E. Gottenberg, Gabriel Baron, Isabelle Pane, Xavier Mariette, Philippe Ravaud, T. Schaeverbeke, Jean Sibilia, J.H. Salmon, X. Le Loët, Damien Loeuille, Christian Marcelli, Thomas Bardin, R.M. Flipo, Eric Houvenagel, Maxime Dougados, Alain Cantagrel, Philippe Gaudin
Publikováno v: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2016, 75 (6), pp.1108-1113. ⟨10.1136/annrheumdis-2015-207362⟩
Annals of the Rheumatic Diseases, 2016, 75 (6), pp.1108-1113. ⟨10.1136/annrheumdis-2015-207362⟩
ObjectivesLittle data are available regarding the rate and predicting factors of serious infections in patients with rheumatoid arthritis (RA) treated with abatacept (ABA) in daily practice. We therefore addressed this issue using real-life data from
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::847c66f093f6f752627bc7e0feda9847
https://hal.univ-lorraine.fr/hal-01451900
Zobrazit plný text záznamu
3
Osteocalcin is not a marker of progress in multiple myeloma
Autor: X. Le Loët, Mathieu Monconduit, Ch. Grisot, Jean-François Ménard, Bernard Grosbois, P. Jego, Liana Euller-Ziegler, O. Mejjad, J. P. Basuyau, Alain Daragon
Publikováno v: European Journal of Haematology. 56:30-34
The aim of this study was to evaluate the usefulness of serum osteocalcin (OC) levels in multiple myeloma (MM) in order to assess its significance and activity, and to predict its course. Serum OC was measurement in 117 patients with MM and 116 healt
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d874aeff3d97ddf0f82cec8e95648ac3
https://doi.org/10.1111/j.1600-0609.1996.tb00289.x
Zobrazit plný text záznamu
4
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
Autor: F Alaoui, D Rosellini, Bruno Fautrel, Chantal Job-Deslandre, Marc Michel, Pierre Quartier, Nicolas Limal, X. Le Loët, Mehdi Khellaf, Emmanuelle Dernis, Club Rhumatismes et Inflammation, Thierry Lequerré, Isabelle Koné-Paut, M. De Bandt, O. Mejjad, J. Sibilia
Publikováno v: Annals of the Rheumatic Diseases. 67:302-308
Background: Anakinra treatment has been reported to be effective in some patients with systemic-onset juvenile idiopathic arthritis (SoJIA) or adult-onset Still disease (AoSD). Objectives: To assess the efficacy and the safety of anakinra treatment i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::420535d05b06726d80ae68aedb94782f
https://doi.org/10.1136/ard.2007.076034
Zobrazit plný text záznamu
5
A cryopyrin-associated periodic syndrome with joint destruction
Autor: Alice Goldenberg, Pascale Saugier-Veber, Thierry Lequerré, Olivier Vittecoq, P. Patoz, X. Le Loët, Thierry Frebourg
Publikováno v: Rheumatology. 46:709-714
Objective. Describe four generations (11 members) of a family with a cryopyrin-associated periodic syndrome (CAPS), including joint destruction, associated with a CIAS1-gene mutation and good responses to anakinra. Methods. In addition to detailed qu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e742ce421f70db373124cab18fea2303
https://doi.org/10.1093/rheumatology/kel399
Zobrazit plný text záznamu
8
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology
Autor: Frédéric Lioté, M De Bandt, Francis Guillemin, A. Saraux, X. Le Loët, Daniel Wendling, René-Marc Flipo, J.-M. Berthelot, Alain Cantagrel, O. Meyer, J.-F. Maillefert, Bernard Combe, Bruno Fautrel
Publikováno v: Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2006, 65 (1), pp.45-50. ⟨10.1136/ard.2005.035436⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2006, 65 (1), pp.45-50. ⟨10.1136/ard.2005.035436⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2006, 65 (1), pp.45-50. 〈10.1136/ard.2005.035436〉
International audience; OBJECTIVE: To elaborate a clinical practice decision tree for the choice of the first disease modifying antirheumatic drug (DMARD) for untreated rheumatoid arthritis of less than six months' duration. METHODS: Four steps were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd48c3303dbe070be9b82bd247d8ae32
https://doi.org/10.1136/ard.2005.035436
Zobrazit plný text záznamu
9
Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis
Autor: Fabienne Jouen, A Gayet, F Leguillou, P. Boumier, X. Le Loët, François Tron, Jean-François Ménard, S. Pouplin, Danièle Gilbert, O. Mejjad, Olivier Vittecoq, I Tabti-Titon, P. Fardellone
Publikováno v: Clinical and Experimental Immunology. 137:606-611
SUMMARYThe objective of this study was to determine the diagnostic and prognostic values of antiglucose-6-phosphate isomerase (GPI) antibodies in patients with very early arthritis. Anti-GPI antibodies were measured by ELISA using purified GPI from r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c77835dfa3810423490f8b27420c662e
https://doi.org/10.1111/j.1365-2249.2004.02552.x
Zobrazit plný text záznamu
10
Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis
Autor: Michel Jolivet, B Inçaurgarat, Dominique Rolland, Fabienne Jouen-Beades, X. Le Loët, Alain Daragon, A Gayet, Gaspard Gervasi, J Legoedec, P. Fardellone, Odile Letourneur, François Tron, Jean-François Ménard, Olivier Vittecoq
Publikováno v: Clinical and Experimental Immunology. 135:173-180
SUMMARY The objective of the study was to determine the diagnostic value for rheumatoid arthritis (RA) of anti-filaggrin autoantibodies (autoAb) recognizing citrullinated recombinant rat filaggrin (ACRF) in community cases of very early arthritis. To
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b4a476f6d87226e0f67e695be3cec7
https://doi.org/10.1111/j.1365-2249.2004.02341.x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje